C17H21NO4
Neat
303.36
Epi-galanthamine N-Oxide; 366485-18-9; Epi-Galantamine N-Oxide; 5BRJ2JZF7W; Galantamine metabolite M17; EPIGALANTAMINE N-OXIDE; UNII-5BRJ2JZF7W; (1S, 12S, 14S)-9-methoxy-4-methyl-4-oxido-11-oxa-4-azoniatetracyclo[8.6.1.01, 12.06, 17]heptadeca-6(17), 7, 9, 15-tetraen-14-ol; 6H-Benzofuro(3a, 3, 2-ef)(2)benzazepin-6-ol, 4a, 5, 9, 10, 11, 12-hexahydro-3-methoxy-11-methyl-, 11-oxide, (4aS, 6S, 8aS)-; (4aS, 6S, 8aS)-4a, 5, 9, 10, 11, 12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a, 3, 2-ef][2]benzazepin-6-ol 11-Oxide; SCHEMBL14591088; DTXSID30650138; FE22728; (4aS, 6S, 8aS)-3-Methoxy-11-methyl-11-oxo-5, 6, 9, 10, 11, 12-hexahydro-4aH-11lambda~5~-[1]benzofuro[3a, 3 and 2-ef][2]benzazepin-6-ol
(1S, 12S, 14S)-9-methoxy-4-methyl-4-oxido-11-oxa-4-azoniatetracyclo[8.6.1.01, 12.06, 17]heptadeca-6(17), 7, 9 and 15-tetraen-14-ol
InChI=1S/C17H21NO4/c1-18(20)8-7-17-6-5-12(19)9-14(17)22-16-13(21-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14+,17+,18?/m1/s1